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1. Introduction  
Validation of an analytical procedure is performed in order to demonstrate that the 
procedure is suitable for its intended use. Validation is performed in order to show that the 
result(s) generated by a particular analytical procedure are reliable and accurate. 
The principles and practices of validation of analytical procedures are covered by the 
International Conference on Harmonisation (ICH) and are published as guideline Q2 (R1), 
"Validation of Analytical Procedures: Text and Methodology". A full discussion of the terms 
and methodology applicable to validation of analytical procedures is provided in these 
documents.  
2. Contents of the validation protocol for analytical method 
- Statement of purpose and scope 
- Responsibilities  
- Documented test method 
- List of materials and equipment 
- Procedure for the experiments for each parameter 
- Statistical analysis 
- Acceptance criteria for each performance parameter 
Full validation is necessary if; 
- The method of synthesis changed from that of patented innovator’s method 
- Changes in the composition of the drug product (excipients, …etc), 
- Changes in the analytical procedure (critical change) 
- Or if the method is not cited in the compendia (USP/BP/Eur. Ph) 
Typical analytical performance characteristics that should be considered : 
Accuracy – Precision – Specificity – Detection limit - Quantitation limit – Linearity – Range – 
Ruggedness[1] 
3. Analytical performance characteristics  
Specificity  
Definition— The ICH documents define specificity as the ability to assess unequivocally the 
analyte in the presence of components that may be expected to be present, such as 
impurities, degradation products, and matrix components. Lack of specificity of an 
individual analytical procedure may be compensated for by other supporting analytical 
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procedures. [NOTE— Other reputable international authorities (IUPAC, AOAC) have 
preferred the term “selectivity,” reserving “specificity” for procedures that are completely 
selective.] For the test or assay methods below, the above definition has the following 
implications:  
Identification tests— ensure the identity of the analyte.  
Purity tests— ensure that all the analytical procedures performed allow an accurate 
statement of the content of impurities of an analyte (e.g., related substances test, heavy 
metals limit, organic volatile impurity limit).  
Assays— provide an exact result, which allows an accurate statement on the content or 
potency of the analyte in a sample[1].  
Determination— In qualitative analyses (identification tests), the ability to select between 
compounds of closely related structure that are likely to be present should be demonstrated. 
This ability should be confirmed by obtaining positive results (perhaps by comparison to a 
known reference material) from samples containing the analyte, coupled with negative 
results from samples that do not contain the analyte, and by confirming that a positive 
response is not obtained from materials structurally similar to or closely related to the 
analyte.  
In an analytical procedure for impurities, specificity may be established by spiking the drug 
substance or product with appropriate levels of impurities and demonstrating that these 
impurities are determined with appropriate accuracy and precision. In an assay, 
demonstration of specificity requires that it can be shown that the procedure is unaffected 
by the presence of impurities or excipients. In practice, this can be done by spiking the drug 
substance or product with appropriate levels of impurities or excipients and demonstrating 
that the assay result is unaffected by the presence of these extraneous materials. If impurity 
or degradation product standards are unavailable, specificity may be demonstrated by 
comparing the test results of samples containing impurities or degradation products to a 
second well-characterized procedure (e.g., a pharmacopeial or other validated procedure). 
These comparisons should include samples stored under relevant stress conditions (e.g., 
light, heat, humidity, acid or base hydrolysis, oxidation). In an assay, the results should be 
compared; in chromatographic impurity tests, the impurity profiles should be compared. 
The ICH documents state that when[2] chromatographic procedures are used, representative 
chromatograms should be presented to demonstrate the degree of selectivity, and peaks 
should be appropriately labeled. Peak purity tests (e.g., using diode array or mass 
spectrometry) may be useful to show that the analyte chromatographic peak is not 
attributable to more than one component. 
Linearity and range  
Definition of Linearity— The linearity of an analytical method is its ability to elicit test results 
that are directly, or by a well-defined mathematical transformation, proportional to the 
concentration of analyte in samples within a given range.  
Definition of Range— The range of an analytical method is the interval between the upper 
and lower levels of analyte (including these levels) that has been demonstrated to be 
determined with a suitable level of precision, accuracy, and linearity using the method as 
written. The range is normally expressed in the same units as test results (e.g., percent, parts 
per million) obtained by the analytical method. [1] 
Determination of Linearity and Range— Linearity should be established across the range of the 
analytical procedure. It should be established initially by visual examination of a plot of 
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signals as a function of analyte concentration of content. If there appears to be a linear 
relationship, test results should be established by appropriate statistical methods (e.g., by 
calculation of a regression line by the method of least squares). In some cases, to obtain 
linearity between the response of an analyte and its concentration, the test data may have to 
be subjected to a mathematical transformation. Data from the regression line itself may be 
helpful for providing mathematical estimates of the degree of linearity. The correlation 
coefficient, y-intercept, slope of the regression line, and residual sum of squares should be 
submitted. The range of the method is validated by verifying that the analytical method 
provides acceptable precision, accuracy, and linearity when applied to samples containing 
analyte at the extremes of the range as well as within the range. 
ICH recommends that, for the establishment of linearity, a minimum of five concentrations 
normally be used. It is also recommended that the following minimum specified ranges 
should be considered: 
Assay of a drug substance (or a finished product): from 80% to 120% of the test concentration.  
Determination of an impurity: from 50% to 120% of the specification.  
For content uniformity: a minimum of 70% to 130% of the test concentration, unless a wider or 
more appropriate range, based on the nature of the dosage form (e.g., metered-dose 
inhalers) is justified[1].  
For dissolution testing: ±20% over the specified range (e.g., if the specifications for a 
controlled-release product cover a region from 20% after 1 hour, and up to 90% after 24 
hours, the validated range would be 0% to 110% of the label claim).  
Example: 
The effect of varying the concentration of Misoprostol on its peak area is given in table 1 
 
Concentration level  
(%) 
Concentration of Misoprostol 
(mcg / ml) 
Peak area of Misoprostol 
60 4.80 355721.5 
80 6.40 473319.5 
100 *8.00 591304.5 
120 9.60 702642 
140 11.20 823837.5 
* Concentration similar to that used in the test solution in the assay method. 
Table 1. Effect of concentration of Misoprostol on its peak area 
The regression equation is: 
PA = C * 72847.15625 + 6587.75  
Where: 
PA: peak area 
C: conc. (mcg / ml)  
Note: Slope: 72847.156 - Intercept: 6587.75 - r: 0.9999, indicting good linear relationship  
-A linear relationship exists between the peak area and the concentration of Misoprostol 
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Fig. 1. A linear relationship exists between the peak area and the concentration of Misoprostol 
[Example was taken from analytical method validation for Misotac 200 mcg tablets, 
produced by SIGMA pharmaceutical industries] 
Accuracy  
Definition— The accuracy of an analytical method is the closeness of test results obtained by 
that method to the true value. The accuracy of an analytical method should be established 
across its range. [2]  
Determination— In assay of a drug substance, accuracy may be determined by application of 
the analytical method to an analyte of known purity (e.g., a Reference Standard) or by 
comparison of the results of the method with those of a second, well-characterized method, 
the accuracy of which has been stated or defined. In assay of a drug in a formulated 
product, accuracy may be determined by application of the analytical method to synthetic 
mixtures of the drug product components to which known amounts of analyte have been 
added within the range of the method. If it is not possible to obtain samples of all drug 
product components, it may be acceptable either to add known quantities of the analyte to 
the drug product (i.e., to “spike”) or to compare results with those of a second, well-
characterized method, the accuracy of which has been stated or defined. In quantitative 
analysis of impurities, accuracy should be assessed on samples (of drug substance or drug 
product) spiked with known amounts of impurities. Where it is not possible to obtain 
samples of certain impurities or degradation products, results should be compared with 
those obtained by an independent method. In the absence of other information, it may be 
necessary to calculate the amount of an impurity on the basis of comparison of its response 
to that of the drug substance; the ratio of the responses of equal amounts of the impurity 
and the drug substance (response factor) should be used if known. 
Accuracy is calculated as the percentage of recovery by the assay of the known added 
amount of analyte in the sample, or as the difference between the mean and the accepted 
true value, together with confidence intervals. 
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The ICH documents recommend that accuracy be assessed using a minimum of nine 
determinations over a minimum of three concentration levels, covering the specified range 
(i.e., three concentrations and three replicates of each concentration) [3]. 
Precision  
Definition— The precision of an analytical method is the degree of agreement among 
individual test results when the method is applied repeatedly to multiple samplings of a 
homogeneous sample. The precision of an analytical method is usually expressed as the 
standard deviation or relative standard deviation (coefficient of variation) of a series of 
measurements. Precision may be a measure of either the degree of reproducibility or 
repeatability of the analytical method under normal operating conditions. In this context, 
reproducibility refers to the use of the analytical procedure in different laboratories, as in a 
collaborative study. Intermediate precision expresses within-laboratory variation, as on 
different days, or with different analysts or equipment within the same laboratory. 
Repeatability refers to the use of the analytical procedure within a laboratory over a short 
period of time using the same analyst with the same equipment. For most purposes, 
repeatability is the criterion of concern in USP analytical procedures, although 
reproducibility between laboratories or intermediate precision may well be considered 
during the standardization of a procedure before it is submitted to the Pharmacopeia.  
Determination— The precision of an analytical method is determined by assaying a sufficient 
number of aliquots of a homogeneous sample to be able to calculate statistically valid 
estimates of standard deviation or relative standard deviation (coefficient of variation). 
Assays in this context are independent analyses of samples that have been carried through 
the complete analytical procedure from sample preparation to final test result.  
The ICH documents recommend that repeatability should be assessed using a minimum of 
nine determinations covering the specified range for the procedure (i.e., three concentrations 
and three replicates of each concentration, or a minimum of six determinations at 100% of 
the test concentration) [3]. 
Detection limit  
Definition— The detection limit is a characteristic of limit tests. It is the lowest amount of 
analyte in a sample that can be detected, but not necessarily quantitated, under the stated 
experimental conditions. Thus, limit tests merely substantiate that the amount of analyte is 
above or below a certain level. The detection limit is usually expressed as the concentration 
of analyte (e.g., percentage, parts per billion) in the sample.  
Determination— For noninstrumental methods, the detection limit is generally determined 
by the analysis of samples with known concentrations of analyte and by establishing the 
minimum level at which the analyte can be reliably detected[3].  
For instrumental procedures, the same method may be used as for noninstrumental. In the 
case of methods submitted for consideration as official compendial methods, it is almost 
never necessary to determine the actual detection limit. Rather, the detection limit is shown 
to be sufficiently low by the analysis of samples with known concentrations of analyte above 
and below the required detection level. For example, if it is required to detect an impurity at 
the level of 0.1%, it should be demonstrated that the procedure will reliably detect the 
impurity at that level. 
In the case of instrumental analytical procedures that exhibit background noise, the ICH 
documents describe a common approach, which is to compare measured signals from 
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samples with known low concentrations of analyte with those of blank samples. The 
minimum concentration at which the analyte can reliably be detected is established. 
Typically acceptable signal-to-noise ratios are 2:1 or 3:1. Other approaches depend on the 
determination of the slope of the calibration curve and the standard deviation of responses. 
Where LOD = 3/Slope  
S = slope of calibration curve 
S may be carried out based on SD of blank or calibration curve 
Whatever method is used, the detection limit should be subsequently validated by the 
analysis of a suitable number of samples known to be near, or prepared at, the detection 
limit. [3] 
Quantitation limit  
Definition— The quantitation limit is a characteristic of quantitative assays for low levels of 
compounds in sample matrices, such as impurities in bulk drug substances and degradation 
products in finished pharmaceuticals. It is the lowest amount of analyte in a sample that can 
be determined with acceptable precision and accuracy under the stated experimental 
conditions. The quantitation limit is expressed as the concentration of analyte (e.g., 
percentage, parts per billion) in the sample.  
Determination— For noninstrumental methods, the quantitation limit is generally determined 
by the analysis of samples with known concentrations of analyte and by establishing the 
minimum level at which the analyte can be determined with acceptable accuracy and 
precision. For instrumental procedures, the same method may be used as for noninstrumental. 
In the case of methods submitted for consideration as official compendial methods, it is 
almost never necessary to determine the actual quantitation limit. Rather, the quantitation 
limit is shown to be sufficiently low by the analysis of samples with known concentrations 
of analyte above and below the quantitation level. For example, if it is required to assay an 
analyte at the level of 0.1 mg per tablet, it should be demonstrated that the method will 
reliably quantitate the analyte at that level. In the case of instrumental analytical methods 
that exhibit background noise, the ICH documents describe a common approach, which is to 
compare measured signals from samples with known low concentrations of analyte with 
those of blank samples. The minimum concentration at which the analyte can reliably be 
quantified is established. A typically acceptable signal-to-noise ratio is 10:1. Other approaches 
depend on the determination of the slope of the calibration curve and the standard deviation 
of responses. Whatever method is used, the quantitation limit should be subsequently 
validated by the analysis of a suitable number of samples known to be near, or prepared at, 
the quantitation limit[3]. 
Ruggedness  
Definition— The ruggedness of an analytical method is the degree of reproducibility of test 
results obtained by the analysis of the same samples under a variety of conditions, such as 
different laboratories, analysts, instruments, lots of reagents, elapsed assay times, assay 
temperatures, or days. Ruggedness is normally expressed as the lack of influence on test 
results of operational and environmental variables of the analytical method. Ruggedness is a 
measure of reproducibility of test results under the variation in conditions normally 
expected from laboratory to laboratory and from analyst to analyst.  
Determination— The ruggedness of an analytical method is determined by analysis of 
aliquots from homogeneous lots in different laboratories, by different analysts, using 
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operational and environmental conditions that may differ but are still within the specified 
parameters of the assay. The degree of reproducibility of test results is then determined as a 
function of the assay variables. This reproducibility may be compared to the precision of the 
assay under normal conditions to obtain a measure of the ruggedness of the analytical 
method[4].  
Robustness  
Definition— The robustness of an analytical method is a measure of its capacity to remain 
unaffected by small but deliberate variations in method parameters and provides an 
indication of its reliability during normal usage.  
System suitability  
If measurements are susceptible to variations in analytical conditions, these should be 
suitably controlled, or a precautionary statement should be included in the method. One 
consequence of the evaluation of ruggedness and robustness should be that a series of 
system suitability parameters is established to ensure that the validity of the analytical 
method is maintained whenever used. Typical variations are the stability of analytical 
solutions, equipment, and analysts. In liquid chromatography, typical variations are the pH 
of the mobile phase, the mobile phase composition, different lots or suppliers of columns, 
the temperature, and the flow rate. In the case of gas chromatography, typical variations are 
different lots or suppliers of columns, the temperature, and the flow rate. System suitability 
tests are based on the concept that the equipment, electronics, analytical operations, and 
samples to be analyzed constitute an integral system that can be evaluated as such. System 
suitability test parameters to be established for a particular method depend on the type of 
method being evaluated. They are especially important in the case of chromatographic 
methods, and submissions to the USP [1]  
4. Data elements required for assay validation 
Compendial assay procedures vary from highly exacting analytical determinations to 
subjective evaluation of attributes. Considering this variety of assays, it is only logical that 
different test methods require different schemes. This chapter covers only the most common 
categories of assays for which data should be required. These categories are as follows. 
Category I: Analytical methods for quantitation of major components of bulk drug 
 substances or active ingredients (including preservatives) in finished 
 pharmaceutical products.  
Category II: Analytical methods for determination of impurities in bulk drug 
 substances or degradation compounds in finished pharmaceutical 
 products. These methods include quantitative assays and limit tests.  
Category III: Analytical methods for determination of performance characteristics (e.g., 
 dissolution, drug release).  
Category IV: Identification tests.  
For each assay category, different analytical information is needed. Listed in Table 2 are data 
elements normally required for each of the categories of assays.  
Already established general assays and tests (e.g., titrimetric method of water determination, 
bacterial endotoxins test) should be revalidated to verify their accuracy (and absence of 
possible interference) when used for a new product or raw material. The validity of an 
analytical method can be verified only by laboratory studies. Therefore, documentation of 
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the successful completion of such studies is a basic requirement for determining whether a 
method is suitable for its intended applications. Appropriate documentation should 














Accuracy Yes Yes * * No 
Precision Yes Yes No Yes No 
Specificity Yes Yes Yes * Yes 
Detection limit No No Yes * No 
Quantitation limit No Yes No * No 
Linearity Yes Yes No * No 
Range Yes Yes * * No 
* May be required, depending on the nature of the specific test. 
Table 2. Data elements required for assay validation[1]  
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